hat
Liothyronine se yon fòm sentetik nan triyodotironin (T3), yon òmòn tiwoyid itilize pou trete ipothyroidism ak komedyen myxedema. T3 se òmòn tiwoyèm metabolik aktif, ki lakòz anpèchman sanblab, epi diminye nivo TSH ki wo. Li ogmante metabolis nan tisi periferik epi li endike lè gen yon konvèsyon ki gen pwoblèm T4 ak T3 nan tisi periferik. Li se tou itilize kòm yon estrateji ogmantasyon nan trete gwo maladi depresyon lè yo itilize nan konbinezon ak antidepreseur.Li se commercialisés kòm sèl nan sodyòm anba mak Non Cytomel a (oswa Tertroxin nan Ostrali).
eng
Liothyronine is a synthetic form of triiodothyronine (T3), a thyroid hormone used to treat hypothyroidism and myxedema coma. T3 is the metabolically active thyroid hormone, which causes feedback inhibition, and lowers elevated TSH levels. It increases metabolism in peripheral tissues and is indicated when there is an impaired conversion of T4 to T3 in peripheral tissues. It is also used as an augmentation strategy in treating major depressive disorder when used in combination with antidepressants.It is marketed as the sodium salt under the brand name Cytomel (or Tertroxin in Australia).